a review of arsenic trioxide and acute promyelocytic leukemia.
نویسندگان
چکیده
arsenic trioxide is an old drug that has recently re- introduced into new medicine. it is very potent against a specific type of leukemic cells harboring translocation between chromosomes 15 and 17. it has been demonstrated that this drug is effective against all stages of acute promyelocytic leukemia, including for remission induction of relapsed cases, or as first-line treatment. it is also useful in the consolidation/maintenance phase of treatment. many trials are ongoing to determine the best and optimum schedule for this drug as a single agent or in combination with other drugs. in the future, its indications might extend to other malignancies. in this review, we will study biologic effects of arsenic trioxide on apl cells and the results of clinical trials on the treatment of apl. we will also discuss the toxicity and minimal residual detection during patient follow-up.
منابع مشابه
A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
Arsenic Trioxide is an old drug that has recently re- introduced into new medicine. It is very potent against a specific type of leukemic cells harboring translocation between chromosomes 15 and 17. It has been demonstrated that this drug is effective against all stages of acute promyelocytic leukemia, including for remission induction of relapsed cases, or as first-line treatment. It is also u...
متن کاملRetinoic acid and arsenic trioxide for acute promyelocytic leukemia.
BACKGROUND All-trans retinoic acid (ATRA) with chemotherapy is the standard of care for acute promyelocytic leukemia (APL), resulting in cure rates exceeding 80%. Pilot studies of treatment with arsenic trioxide with or without ATRA have shown high efficacy and reduced hematologic toxicity. METHODS We conducted a phase 3, multicenter trial comparing ATRA plus chemotherapy with ATRA plus arsen...
متن کاملClinical experience of arsenic trioxide in relapsed acute promyelocytic leukemia.
Acute promyelocytic leukemia (APL) has unique clinical, cytogenetic, and molecular features and is one of the most potentially curable human malignancies. The current standard treatment given to patients with newly diagnosed APL consists of all-trans retinoic acid and anthracycline-based cytotoxic chemotherapy, which is highly effective for remission induction. However, despite the potential fo...
متن کاملTreatment of Acute Promyelocytic Leukemia with Single-Agent Arsenic Trioxide
It is well recognized that arsenic trioxide (ATO) is an efficacious agent for the treatment of acute promyelocytic leukemia (APL). Use of single agent ATO in the treatment of APL leads to remissions which are durable in the majority. ATO is probably the most effective single agent in the treatment of APL and there have been very few reports of primary resistance. It has been used both as a sing...
متن کاملArsenic trioxide as effective therapy for relapsed acute promyelocytic leukemia.
The standard of treatment for newly diagnosed patients with acute promyelocytic leukemia (APL) is all-trans retinoic acid (ATRA) plus anthracycline-based cytotoxic chemotherapy, a combination that is highly effective for remission induction. However, 20%-30% of patients relapse and require salvage therapy. Reports from China on the striking efficacy and safety of arsenic trioxide in patients wi...
متن کاملArsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
Arsenic trioxide has been successfully used as a therapeutic in the treatment of acute promyelocytic leukemia (APL). Detailed monitoring of the therapeutic arsenic and its metabolites in various accessible specimens of APL patients can contribute to improving treatment efficacy and minimizing arsenic-induced side effects. This article focuses on the determination of arsenic species in saliva sa...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
international journal of hematology-oncology and stem cell researchجلد ۸، شماره ۳، صفحات ۴۴-۵۴
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023